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Abstract: In this study, we demonstrated the involvement of matrix metalloproteinases (MMPs)
in hepatic ischemia/reperfusion (I/R) injury. Our aim is to evaluate the impact of reperfusion on
I/R-related changes in RECK, an MMP modulator, and mitogen-activated protein kinase (MAPKs)
pathways (ERK, p38, and JNK). Male Wistar rats were either subjected to 60 min partial-hepatic
ischemia or sham-operated. After a 60 min or 120 min reperfusion, liver samples were collected for
analysis of MMP-2 and MMP-9 by zymography and RECK, TIMP-1, and TIMP-2 content, MAPKs
activation (ERK1/2, JNK1/2, and p38), as well as iNOS and eNOS by Western blot. Serum enzymes
AST, ALT, and alkaline-phosphatase were quantified. A transitory decrease in hepatic RECK and
TIMPs was associated with a transitory increase in both MMP-2 and MMP-9 activity and a robust
activation of ERK1/2, JNK1/2, and p38 were detected at 60 min reperfusion. Hepatic expression of
iNOS was maximally upregulated at 120 min reperfusion. An increase in eNOS was detected at
120 min reperfusion. I/R evoked significant hepatic injury in a time-dependent manner. These findings
provide new insights into the underlying molecular mechanisms of reperfusion in inducing hepatic
injury: a transitory decrease in RECK and TIMPs and increases in both MAPK and MMP activity
suggest their role as triggering factors of the organ dysfunction.
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1. Introduction
Hepatic ischemia/reperfusion (I/R) injury may occur in a variety of clinical situations, including
transplantation, liver resection, trauma, and vascular surgery. The reperfusion after ischemia may
trigger I/R injury exacerbating cellular damage. The effects of reperfusion include excessive production
of reactive oxygen species, oxidative stress, mitochondrial dysfunction, and systemic inflammatory
response. Neutrophils play a critical role during the initial phase of I/R (0–6 h) triggering activation of
pro-inflammatory intracellular cascades. One of the best characterized pathways within the context of
organ I/R injury is the mitogen-activated protein kinase (MAPKs) family [1]. Among MAPKs, p38,
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JNK1/2, and ERK 1/2, activated by a variety of cellular stressors including I/R, could potentially serve
as potential targets in hepatic I/R injury [2,3].
Hepatic I/R injury is also connected with matrix metalloproteinases (MMPs) gene expression,
activation, and release concomitant with alterations of tissue integrity [4]. The MMPs are a family of
24 proteases using zinc-dependent catalysis to breakdown extracellular matrix (ECM) components,
allowing cell movement and tissue reorganization. Furthermore, MMP-2 and MMP-9 play a crucial
role as they are the main components of Disse’s space composed of loose extracellular matrix (ECM) [5].
We previously demonstrated that dysregulated expression and activation of MMPs are involved
in hepatic injury and that changes in MMP activities already occur during the early phases of
reperfusion [6]. Among different MMPs, MMP-9 is emerging as an important mediator of leukocyte
traffic in hepatic I/R [7]. MMP-9 plays a crucial role in leukocyte recruitment and activation leading
to liver I/R damage [8]. MMP-9(-/-) mice and mice treated with an anti-MMP-9 antibody showed
significantly reduced I/R damage, altered neutrophil migration, and depressed myeloperoxidase
(MPO) activation [8]. Of note, the regulation of MMP activity appears as a multifaceted process;
in particular, the relationship between the production of nitric oxide (NO) by inducible NO synthase
(iNOS) and MMP-9 induction has obtained much attention over the last few years [9]. Selective
iNOS inhibition down-regulates MMP-9 activity and disrupts leukocyte migration in hepatic I/R
injury [10]. Most recent studies demonstrate that the activity of MMP-2 or MMP-9 is reduced
by interaction with the reversion-inducing-cysteine-rich protein with kazal motifs (RECK) [11,12].
Recently, a study discovered RECK isoforms with opposing effects on cell migration: the short
isoform appears to compete with MMP-9 for binding to the long RECK isoform [13]. RECK was
identified as a transformation-suppressor gene which, regulating the expression of several MMPs,
is involved in the inhibition of the tumor invasion and metastasis process [14]. RECK contains
a glycosylphosphatidylinositol domain and a number of cysteine residues. It presents differences in
the amino acid sequence when compared with the tissue inhibitors of metalloproteinases (TIMPs),
which makes RECK an innovative membrane-targeted MMP regulator [14]. Besides, our understanding
of the time course of activation of signaling cascades exerting a key role in liver injury following
reperfusion remains incomplete and warrants further investigation.
Thus, the aim of the present study is to evaluate the impact of reperfusion on RECK and MAPK
signaling pathways under hepatic I/R conditions. Their correlations with markers of organ dysfunction,
such as MMP activity, iNOS, and eNOS were further investigated to better describe pathogenic
mechanism(s) suitable for pharmacological modulation.
2. Materials and Methods
2.1. Materials
All reagents were of the highest grade of purity available and were obtained from Sigma-Aldrich
(Milan, Italy).
2.2. Animals and Experimental Design
Male Wistar rats (Harlan-Nossan, Italy) were used in this study. The animals were allowed free
access to water and food in all the experiments. The use and care of animals in this experimental study
was approved by the Italian Ministry of Health and by the University of Pavia Commission for Animal
Care (Document number 179/2017-PR). The effects of I/R were studied in vivo in a partial normothermic
hepatic I/R model (n = 18). The rats were anesthetized with sodium pentobarbital (40 mg/kg i.p.),
the abdomen was opened via a midline incision. Ischemia to the left and the median lobe was induced
for 60 min with microvascular clips by clamping the branch of portal vein and the branch of the hepatic
artery after the bifurcation to the right lobe, with the abdomen temporarily closed with a suture [6].
After 60 min of ischemia, the abdomen was reopened, the clips were removed, the abdomen was closed
again, and the liver was allowed to reperfuse for 60 or 120 min. By using partial, rather than total,
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hepatic ischemia, portal vein congestion and subsequent bacterial translocation into the portal venous
blood was avoided. Sham animals were subjected to the same procedure without clamping the vessels
(n = 12). To prevent postsurgical dehydration and hypotension, 1 mL of saline was injected into the
inferior vena cava. All the animals were maintained on a warm support to prevent heat loss with
rectal temperature at 37 ± 0.1◦C. Animals were sacrificed under general anesthesia by exsanguination.
Blood was drawn from the vena cava and allowed to clot at room temperature. After 15 min serum
was centrifuged at 3000× g for 10 min at 4◦C. At the end of ischemia or after 60 min or 120 min
reperfusion, hepatic biopsies were quickly removed from the median lobe and immediately frozen in
liquid nitrogen, as were serum samples.
2.3. Biochemical Assays
Liver injury was assessed by serum levels of alanine transaminase (ALT), aspartate transaminase
(AST), and alkaline phosphatase (ALP). Total and direct bilirubin were quantified using standard
commercial kits (Merck, Italy).
2.4. Gelatin Zymography
Protein extraction from snap-frozen samples and gelatin zymography were performed as described
previously [15]. To detect MMP lytic activity samples were homogenized in an ice-cold extraction buffer
and protein content was normalized by a final concentration of 400µg/mL in the sample loading buffer
(0.25 M Tris-HCl, 4% sucrose w/v, 10% SDS w/v, and 0.1% bromphenol blue w/v, pH 6.8). After dilution,
the samples were loaded onto electrophoretic gels (SDS-PAGE), containing gelatin, under nonreducing
conditions. Following the electrophoretic run, the gels were washed twice and were incubated at 37 ◦C.
To reveal zones of lysis, gels were stained with Coomassie Blue. The zymograms were analyzed by
a densitometer (GS 900 Densitometer BIORAD, Hercules, CA, USA), and proteinases activity was
expressed as optical density (OD), reported to 1 mg/mL protein content.
2.5. Western Blot Assay
Liver tissue samples were homogenized in an ice-cold Lysis Buffer supplemented with Protease
Inhibitor Cocktail and centrifuged at 15,000 g for 10 min. The collected supernatant was stored at
−80 ◦C. Samples of liver extracts containing the same amount of proteins were separated in SDS-PAGE
on 7.5% acrylamide gels and transferred to PVDF membrane. Unspecific sites were blocked for 2 h with
5% Bovine Serum Albumin (BSA) in TBS Tween (20 mMTris/HCl, 500 mM NaCl, pH 7.5, 0.1% Tween 20)
at 4 ◦C. The membranes were incubated with primary antibodies overnight at 4 ◦C, under gentle
agitation. Primary antibodies against mouse monoclonal alpha tubulin (DM1A), mouse monoclonal
anti-RECK, mouse monoclonal anti-eNOS, mouse monoclonal anti-Phospho-JNK (Thr183/Tyr185),
mouse monoclonal anti-Phospho-p38 (Thr180/Tyr182), rabbit monoclonal anti-Phospho-ERK1/2
(Thr202/Tyr204), rabbit monoclonal anti-ERK1/2, rabbit polyclonal antibody anti-iNOS, rabbit polyclonal
anti-JNK, and rabbit polyclonal anti-p38 were used at 1:1000 dilution. Rabbit polyclonal anti TIMP-1 and
TIMP-2 were used at 1:200. Membranes were washed in TBS Tween (Na2HPO4 8 mM, NaH2PO4-H2O
2 mM, NaCl 140 mM, pH 7.4, 0.1% Tween 20) and incubated with peroxidase-conjugated secondary
anti-Rabbit or anti-Mouse antibodies at a 1:2000 dilution. The membranes were then stripped and
incubated with tubulin monoclonal antibody (1:5000) and subsequently with anti-mouse (1:10,000)
to assess uniformity of gel loading. Anti-iNOS was purchased from Cayman Chemical (Ann Arbor,
Michigan, USA). RECK and eNOS were bought from Santa Cruz Biotechnology. Mouse monoclonal
antibody against TIMP-1 and TIMP-2 were purchased from Thermo Fisher Scientific (USA For
the detection of MAPKs, the antibodies were obtained from Cell Signaling Technology [LS1]
(Leiden, the Netherlands). Immunostaining was revealed with BIO-RAD Chemidoc XRS+ visualized
using the ECL Clarity BIO-RAD (Milan, Italy). Bands intensity quantification was performed by
BIO-RAD Image Lab Software™ 6.0.1., and autoradiograms showing statistically significant differences
in terms of gel-loading homogeneity were excluded from the following biomarkers analyses.
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2.6. Liver Histology
Liver biopsies were rapidly removed, fixed in 2% p-formaldehyde in 0.1 M phosphate buffer at
pH 7.4 for 24 h and processed routinely until they were embedded in Paraplast wax. Sections were cut
at 7 µm and stained with Hematoxylin and Eosin (H&E) for histological examination [16]
2.7. Statistical Analysis
Results are expressed as means value ± standard error (SE) for all data. The value of p < 0.05
was considered the criterion for statistical significance. To assess normality of variance changes,
the Kolmogorov–Shapiro normality test was used. Data were analyzed by ANOVA with Tukey’s
multiple comparison test as post-hoc test or Kruskall–Wallis and Dunn’s test, as appropriate. Statistical
Analysis was performed using MedCalc Statistical Software version 18.11.3 (MedCalc Software bvba,
Ostend, Belgium; https://www.medcalc.org; 2019).
3. Results
3.1. Transient Expression of Reck, Mmps, and Timps in a Rat Model of Hepatic I/R Injury
To study the expression of RECK under hepatic I/R, we used a rat model of partial I/R injury.
After 60 min reperfusion, a time-dependent increase in serum levels of AST, ALT, ALP, and total and
direct bilirubin was observed (Table 1).
Table 1. Serum levels of AST, ALT, ALP (U/L), and total and direct bilirubin (mg/dL).
Sham 60/60 I/R 60/60 Sham 60/120 I/R 60/120
AST 243 ± 57 3444 ± 1062 198 ± 43 10,387 ± 1158 *
ALT 66 ± 19 3830 ± 961 61 ± 28 9320 ± 1040 *
ALP 431 ± 50 605 ± 51 417 ± 55 769 ± 29 *
Total Bilirubin 0.13 ± 0.024 0.25 ± 0.070 0.12 ± 0.011 0.35 ± 0.043
Direct Bilirubin 0.045 ± 0.019 0.17 ± 0.032 0.04 ± 0.024 0.18 ± 0.013
Aspartate transaminase, AST; alanine transaminase, ALT; alkaline phosphatase, ALP; * p < 0.05.
This trend was supported by histological analysis (Figure 1). Livers from sham-operated animals
showed well-preserved hepatic architecture while I/R caused marked injury to the parenchyma with
sinusoid dilatation, extensive areas of cytoplasmic vacuolation, and wide areas of necrotic cells detached
from the parenchyma, especially after 120 min reperfusion.
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Figure 1. Liver histology at the end of reperfusion. Paraplast-embedded sections were cut at 7 µm and
stained with H&E. Panel (A) and (C): 60/60 and 60/120 min sham-operated rats, respectively. Panel (B)
and (D): rats submitted to ischemia followed by 60 or 120 min reperfusion, respectively.
The results of RECK protein analysis showed a significant decrease in RECK only at 60 min
reperfusion when compared with 60 min ischemia or 120 min reperfusion or sham-operated groups;
a complete recovery of RECK levels was found at 120 min reperfusion (Figure 2, Panel A). In addition,
no changes in RECK content at the end of ischemia occurred when compared with sham-operated
group. The opposite trend occurred for both MMP-2 and MMP-9 activities that increased after 60 min
reperfusion when compared with sham-operated rats followed by a significant decrease in both hepatic
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MMP activities detectable at 120 min reperfusion comparable with those found in sham-operated
rats (Figure 2, Panel B). The analysis of TIMP-1 showed a decrease after 60 min reperfusion but was
re-expressed at 120 min reperfusion relative to the 60 min time point. No differences in expression
between TIMP-2 were detected between 60 min versus 120 min reperfusion (Figure 2, Panel C).
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3.2. Transient Expression of Mapks under Hepatic I/R
Animals that had undergo e 60 min ischemia followed by 60 min reperfusion displayed higher
phosphorylation of MAPKs (ERK1/2, JNK1/2 and p38) expression than ischemia or sham-operated
animals (Figure 3 A–C), suggesting an early enhancement of the activation of these pathways by I/R
injury. On the contrary, the longer I/R challenge resulted in lower expression levels of the MAPK
phosphorylated forms, with values similar to those recorded in sham-operated animals, thus indicating
a time-dependent quenching of I/R-injury. No significant changes in expression of total MAPK isoforms
were recorded in ischemia group as well in sham-operated rats.
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3.3. Changes in Enos and Inos Expression Under Hepatic I/R
At 120 min reperfusion, a significant increase in eNOS expression was found and it was about
3-fold compared with sham-operated or 60 min reperfused animals (Figure 4, Panel A). Changes
in iNOS expression emerged comparing sham and I/R treated groups both after 60 min or 120 min
reperfusion: a time-dependent increase in iNOS content was found (Figure 4, Panel B).
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4. Discussion
The present data provide new insights into the underlying molecular mechanisms that occur
during reperfusion in hepatic I/R injury: a transitory decrease in RECK and TIMPs, concomitant
with an increases in both MAPK and MMP activity, suggests their role as triggering factors of the
organ dysfunction.
As previously documented, the kinetics of the reperfusion injury may also affect the entity of
the expression and activation of MAPK signaling pathways involved in the I/R-induced damage [17].
A crucial intracellular step that can counteract the deleterious effects of I/R injury is the selective
activation of MAPK. A time-course experiment of MAPK expression after liver I/R showed an increase
in phosphorylation of each MAPK (ERK1/2, JNK1/2, and p38), detectable after 60 min reperfusion and
the activation decreased after 3 h reperfusion, especially for JNK [18]. Here we confirmed the early
and transient MAPK activation, coming back to values similar to those recorded in basal condition
after 120 min reperfusion.
In keeping with the data on MAPK activation, when we measured MMP-2 and MMP-9 activity as
well as the expression of their respective TIMP physiological inhibitors in the liver homogenates, we
found a parallel between the early and transient activation of MMP-2 and MMP-9 and that observed
for MAPKs, suggestive of simultaneous contribution to I/R-induced protein expression changes.
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Here, for the first time, we demonstrated that both MMP-2 and MMP-9 over activation at 60
min was associated with RECK down-regulation, whereas the up-regulation of RECK expression was
recorded at 120 min when no significant MMP activation was detectable. It has been reported that RECK
overexpression decreases the amount of active MMP-2 and MMP-9 in conditioned medium and inhibits
metastatic activity in vitro [19] and in vivo [12]. The evaluation of genotypes among hepatocellular
carcinoma (HCC) patients suggested a possible involvement of RECK gene rs11788747 polymorphism
in increasing the susceptibility of individuals to HCC [20]. In addition, RECK expression was found to
be reduced in kidney epithelial cells subjected to hypoxia [21]. Here, for the first time, we demonstrated
that modulation of RECK expression following liver I/R injury was paralleled by changes in MMP-2
and MMP-9 activation, thus suggesting a potential cross-talk mechanism linking these two signaling
cascades. Our results were supported by findings reported in a recent study using a rat model of
cerebral ischemia [22]. Besides, we did not measure activation of signaling cascades (neither at the
very beginning of reperfusion, nor in non-ischemic liver lobes; thus, we cannot offer a comprehensive
understanding here of all the kinetics factors potentially affecting their expression and activation.
MMPs and TIMPs play also an important function in the preservation of liver homeostasis [23]. In
particular, the major endogenous regulator of MMP-9, TIMP-1, exerts a protective role in the control
of the survival of liver cells during I/R injury [24]. Curzio et al. reported that TIMP-1 was induced
following liver I/R with an earlier induction so we can hypothesize that the failure to recover TIMP-2
at 120 min is due to slower induction times [25]. In addition, TIMP-1 has been reported to play the
major protective role: the inability of TIMP-1−/− mice to express TIMP-1 resulted in enhanced liver
damage and in lethal hepatic I/R injury [24]. Our data support these results: an opposite trend was
found comparing MMP-9 activation versus TIMP-1 content.
RECK downregulation under hypoxic conditions has been demonstrated to be mediated by
involvement of ERK1/2, JNK, and p38 MAPK signaling pathways [26]. The same authors demonstrated
that inhibition of the MAPK signaling pathways restores RECK expression and its ability to affect MMP
activity. In particular, activation of the p38 pathway and p38-associated inflammatory processes play a
crucial role in post-ischemic damage [27]. Although several studies have demonstrated a detrimental
role of JNK activation in I/R injury [28], the results about a protection by JNK inhibition are still
controversial [27,29]. There are also studies indicating the potential involvement of ERK 1/2 in hepatic
I/R injury [30]; to date, the potential role of ERK1/2 as a therapeutic target for liver I/R injury has not
been clarified yet, because the molecules used are also able to modulate other pathways different from
ERK1/2 [28]. However, liver protection against I/R injury was recently obtained via suppressing the
MAPK signaling [1]. Although we demonstrated a time-dependent effect of reperfusion injury on the
cross-talk mechanisms linking RECK expression to MAPK activity, we cannot rule out the potential
impact of the kinetics of the ischemia injury on the activation/expression of the tested signaling cascades.
In fact, as shown by Cursio and colleagues [18], a longer kinetics of ischemia (120 min of normothermic
liver ischemia) resulted in sustained p38 MAPK activation until 3 h reperfusion, whereas, in keeping
with our findings, ERK1/2 degree of activation already decreased after 1 h reperfusion.
We also showed no significant differences in RECK and MAPK content between ischemic
livers without reperfusion and either the sham-operated and 120 min reperfusion groups, thus
confirming that activation of the signaling cascades is mainly related to the reperfusion injury in our
experimental conditions.
Once the MAPK pathway is activated, MAPKs phosphorylate downstream protein kinases and
transcription factors, resulting in upregulation of both iNOS and eNOS. Under normal conditions, only
eNOS is present in the liver, and low levels of NO regulate the hepatic perfusion [31]. Alternatively,
the excess production of NO, generated primarily by iNOS, has been implicated as a mediator of
cellular injury at sites of inflammation, including liver I/R injury [32]. Under these circumstances,
NO reacts with molecular oxygen or superoxide and generates reactive nitrogen species, which may
interfere with many biological functional and structural processes of liver injury evoked by hepatic I/R,
including ECM degradation [10]. Here, we confirmed that the early MAPK activation resulted following
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overexpression of iNOS and eNOS, leading to excessive NO production, which contributes to the liver
damage [33] and also remote organs [34]. Besides, specific iNOS inhibition has been demonstrated
to down-regulate MMP-9 activity and disrupts leukocyte migration in hepatic I/R injury [10]. These
findings further support the mechanistic loop linking MAPKs to MMPs here described. However,
only the use of drugs that specifically inhibit these signaling cascades may allow to identify a causal
relationship between these two pathways and their modulation by RECK. Unfortunately, the lack of
knowledge of the in vivo pharmacological profile of highly selective pharmacological inhibitors limits
further investigation.
5. Conclusions
In conclusion, we demonstrated that the kinetics of reperfusion selectively affect the activation
of signaling pathways involved in hepatic I/R injury. Both MAPKs and MMPs showed an early and
transient activation, which contribute to the development of organ dysfunction and injury. Our data
show that reperfusion-induced modulation of RECK expression is paralleled by opposite changes
in MAPK activation and MMP activity. These findings may contribute to better understanding
intracellular pathways cross-regulation sensitive to liver I/R injury and, thus, to providing the rationale
for much needed novel agents to fill the current therapeutic gaps. However, further studies are needed
to better clarify the reciprocal interaction of these pathways for a wider understanding of the intricate
network of cellular and functional interactions leading to I/R-related liver injury.
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